Carl Haggård

Affiliated to Research
Visiting address: Entrévägen 2, 18257 Danderyd
Postal address: D1 Kliniska vetenskaper, Danderyds sjukhus, D1 Kardiologi Hjärtsvikt, 171 77 Stockholm
Part of:

Articles

All other publications

Grants

  • Stockholm Region Innovation Fund 200 000 SEK
  • Swedish Research Council Project Grant 1 200 000 SEK
  • ALF Medicine 1 000 000 SEK

Employments

  • Affiliated to Research, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2023-2026
  • Resident Physician in internal medicine and cardiology, Danderyd Hospital, 2018-2026
  • Intern, Danderyd Hospital, 2016-2018
  • Junior physician, Department of Cardiology, Danderyd Hospital, 2015-2016
  • Junior physician, Department of Cardiology, Skåne University Hospital, 2014-2014

Degrees and Education

  • PhD (The balance between under- and over-immunosuppression after heart transplantation with emphasis on acute cellular rejection and chronic kidney disease. Experiences from Skåne University Hospital in Lund 1988-2010), Lund University, 2017
  • Physician, Lund University, 2015
  • Clinical electives in cardiology and cardac surgery, Yale University, 2015

Leadership and responsibility assignments

  • Research team leader, The CLUE-project (Congestion via LUng and IVC Evaluation): Point-of-care ultrasound (POCUS)–based decision support in heart failure during the transition from inpatient to outpatient care - a pragmatic randomized trial with integrated observational substudies, Karolinska Institute, 2025-
  • Responsible for a section, Heart–Kidney Failure Research Program: Integrated clinical and epidemiological research on combined heart–kidney failure, comprising pilot interventional studies, population-based analyses, and doctoral supervision. As principal investigator of SCARF-1 (https://clinicaltrials.gov/study/NCT07029503), a pilot interventional study evaluating mineralocorticoid receptor antagonist therapy in patients with heart failure with reduced ejection fraction and advanced chronic kidney disease, the program aims to inform a subsequent national randomized controlled trial, Karolinska Institute, 2024-
  • Responsible for a section, Local subinvestigator in the international randomized controlled trials MIRACLE (https://clinicaltrials.gov/study/NCT04595370), MARITIME-HF (https://clinicaltrials.gov/study/NCT07037459) and EASi-PROTKT (https://clinicaltrials.gov/study/NCT06424288), Karolinska Institute, 2022-
  • Responsible for a section, “Academic Thursdays” at Sweden’s largest cardiology department: a weekly academic program including journal clubs and internal and external research seminars, Karolinska Institute, 2022-

News from KI

Events from KI